8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2024 / Double-blind randomized controlled trial
A double-blind clinical trial evaluated the effect of vitamin B12 supplementation versus placebo for one month in 140 patients with idiopathic tinnitus. There were no statistically significant differences in tinnitus severity based on VAS scores between groups at baseline (p = 0.560), one month (p = 0.485), or three months (p = 0.254). Similarly, THI scores showed no significant differences between groups at baseline (p = 0.651), one month (p = 0.125), or three months (p = 0.089), nor by hearing loss status. No noticeable side effects were observed in either group.
Dadgarnia M, Mandegari M, Zand V, et al. Am J Otolaryngol, 2024. PMID 37647778
2024 / Double-blind randomized controlled trial
In a 24-week double-blind randomized trial, 80 patients with NASFL were assigned to 500 mg/day curcumin or placebo. Compared with placebo, curcumin significantly reduced controlled attenuation parameters (-17.5 dB/m; P < 0.001), body weight (-2.6 kg; P < 0.001), BMI (-1.0 kg/m2; P = 0.032), free fatty acids, triglycerides, fasting blood glucose, HbA1c, and insulin. Curcumin also decreased the Firmicutes to Bacteroidetes ratio, increased Bacteroides abundance, elevated serum deoxycholic acid and glucagon-like peptide-1, and increased TGR5 expression.
He Y, Chen X, Li Y, et al. Am J Clin Nutr, 2024. PMID 38795741
2024 / Randomized controlled trial
Sixty healthy Egyptian adults were randomized to take daily cold or hot showers for 90 days, with blood samples measured at baseline, 30, 60, and 90 days. The cold shower group showed significant increases in immunoglobulin levels and elevated IL-2 and IL-4 levels at 90 days. In contrast, the hot shower group had a significant decrease in IgM at 60 and 90 days without significant changes in cytokine levels. No significant differences were observed in IFN-γ and TNF-α levels between groups.
El-Ansary MRM, El-Ansary AR, Said SM, et al. J Therm Biol, 2024. PMID 39299098
2024 / Randomized, double-blind split-mouth clinical trial
In a randomized, double-blind split-mouth trial, 20 patients aged 18-25 years took kale extract (500 mg anthocyanin equivalent) or ibuprofen (400 mg) capsules for 7 days following surgical removal of impacted teeth. VAS pain scores and salivary α-amylase decreased 7 days after extractions in both groups, with kale extract reported as more effective than ibuprofen. MMP-9 and TGF-β2 levels were reduced on days 4 and 7 following both extractions in the kale group, compared to reductions on days 4 and 7 only after the first extraction in the ibuprofen group.
Chatupos V, Neelawatanasook S, Sangutai T, et al. Nutrients, 2024. PMID 39599607
2023 / Randomized controlled trial
Sixty-three obese adults with tinnitus were randomized into diet + physical activity (n=15), diet (n=16), physical activity (n=15), or control (n=17) groups. Body weight decreased significantly in the diet + physical activity (-5.9 (3.5) kg), diet (-3.4 (0.9) kg), and physical activity (-2.0 (2.1) kg) groups compared to baseline (p < 0.05). Participants achieving ≥5.0% weight loss experienced greater reductions in tinnitus frequency, severity, and VAS scores than those with <5.0% weight loss (p < 0.05). Each 1 kg/m2 decrease in BMI reduced the BDI score by 0.485 units and the THI score by 0.523 units, while each 1,000-step increase decreased the THI score by 0.750 units and increased the SF-36 score by 1.592 units.
Özbey-Yücel Ü, Uçar A, Aydoğan Z, et al. Auris Nasus Larynx, 2023. PMID 35568580
2023 / Randomized controlled trial
A community-based randomized controlled trial evaluated the effects of water immersion at 20-30°C (20 min/day for 4 weeks) versus a control group among 76 acute gout patients in Indonesia. Compared to baseline and control, water immersion led to significant pain alleviation at 2 weeks (β = -2.06) and 4 weeks (β = -2.42), as well as improved quality of life at 2 weeks (β = 5.34) and 4 weeks (β = 9.93). Urate levels decreased at 2 weeks (β = -0.34, 95% CI: -0.52 to -0.16) but showed no significant change in NLRP1 inflammasome concentrations across 4 weeks.
Kurniasari MD, Karwur FF, Rayanti RE, et al. Biol Res Nurs, 2023. PMID 36207143
2023 / Randomized controlled trial
Postmenopausal women were randomized to a 12-week intervention including a low-fat, vegan diet and cooked soybeans (1/2 cup [86 g] daily) or a control group with no dietary changes. In the intervention group, moderate-to-severe hot flashes decreased by 88% compared to 34% in the control group (between-group P < 0.001). At 12 weeks, 50% of completers in the intervention group reported no moderate-to-severe hot flashes, compared to no change from baseline among controls (P < 0.001). The intervention group also experienced greater reductions in vasomotor (P = 0.004), physical (P = 0.01), and sexual (P = 0.03) domains of quality of life, with improvements independent of equol production status or seasonality.
Barnard ND, Kahleova H, Holtz DN, et al. Menopause, 2023. PMID 36253903
2023 / Parallel-arm, assessor-blind randomized controlled trial
In the 'Plants for Joints' trial, 83 patients with rheumatoid arthritis and low-to-moderate disease activity were randomized to a 16-week lifestyle program (whole-food plant-based diet, physical activity, and stress management) or usual care. After 16 weeks, the lifestyle group achieved a 0.9-point greater improvement in DAS28 compared to control (95% CI 0.4, 1.3; P < 0.0001). The intervention also led to greater decreases in body weight (-3.9 kg), fat mass (-2.8 kg), waist circumference (-3 cm), HbA1c (-1.3 mmol/mol), and LDL cholesterol (-0.32 mmol/l), with no changes observed in patient-reported outcomes, blood pressure, glucose, or other lipids.
Walrabenstein W, Wagenaar CA, van der Leeden M, et al. Rheumatology (Oxford), 2023. PMID 36617162
2023 / Randomized controlled trial
Sixty-nine tinnitus patients aged 40-70 were randomized to receive placebo (n=22), Ginkgo biloba (60 mg twice daily) alone (n=24), or Ginkgo biloba combined with antioxidants (n=23) across 14 weeks. Supplementation with Ginkgo biloba plus antioxidants produced marked improvement (p<0.05) in post-treatment THI and VAS scores compared to Ginkgo alone and placebo. The greatest percent differences pre- and post-treatment in the combination group were -36% for THI and -22.6% for VAS (p<0.05), alongside significant improvements in various SF-36 quality-of-life parameters.
Chauhan B, Arya S, Chauhan K J Audiol Otol, 2023. PMID 36710418
2023 / Randomized counterbalanced crossover trial
Twelve semi-professional soccer players completed the Loughborough Intermittent Shuttle Test followed by cold water immersion (CWI; 15 min at 11°C), a placebo recovery beverage, or passive rest across three separate weeks. Compared to baseline, creatine kinase was elevated at 24 h in all conditions (p < 0.01), while CRP rose at 24 h only in CWI and Rest (p < 0.01). Squat jump and countermovement jump performances dropped significantly in the Rest condition at 24 h and 48 h (p <= 0.003) but not in CWI or placebo conditions, and DOMS was higher in Rest than in CWI and placebo at 24 h (p = 0.001). The authors conclude that CWI and placebo were more effective than rest, suggesting CWI's effectiveness may be explained, at least in part, by the placebo effect.
Nasser N, Zorgati H, Chtourou H, et al. Front Physiol, 2023. PMID 36895634
2023 / Randomized controlled trial
Sixty-six patients with hip or knee metabolic syndrome-associated osteoarthritis were randomized to a 16-week multidisciplinary lifestyle program (whole food plant-based diet, physical activity, stress management) plus usual care, or usual care alone. After 16 weeks, the intervention group had an 11-point larger improvement in WOMAC score compared to controls (95% CI 6-16; p = 0.0001). The intervention group also lost more weight (-5 kg), fat mass (-4 kg), and waist circumference (-6 cm), and had greater improvements in PROMIS fatigue, pain interference, CRP, HbA1c, fasting glucose, and LDL.
Walrabenstein W, Wagenaar CA, van de Put M, et al. Osteoarthritis Cartilage, 2023. PMID 37328047
2022 / Randomized, double-blind, placebo-controlled trial
In a randomized, double-blind, placebo-controlled trial, 16 patients with allergic rhinitis were assigned to receive cetirizine (10 mg daily) plus either 3 g of oral shallot per day or placebo capsules for 4 weeks. After 4 weeks, 62.5% of patients in the shallot group and 37.5% in the control group showed improvement in post-treatment visual analog scores of overall symptoms. Total nasal symptom scores decreased significantly in both groups without a significant between-group difference (P = 0.18), whereas total ocular symptom scores improved significantly only in the shallot group (P = 0.01). Adverse events from shallot did not differ from placebo.
Arpornchayanon W, Klinprung S, Chansakaow S, et al. Asian Pac J Allergy Immunol, 2022. PMID 31421664
2022 / Statistical reanalysis of a 1944 double-blind controlled trial
Researchers statistically analyzed published individual participant data on scar strength from a double-blind controlled trial initiated in 1944. An average vitamin C intake of 10 mg/d over a mean follow-up of 11.5 months was associated with a 42% weakened scar strength compared with 80 mg/d (P < 0.001). Additionally, with an average intake of 65 mg/d over a mean follow-up of 6.5 months, vitamin C-depleted tissues had a 49% weaker scar strength when compared with nondepleted tissues (P < 0.05). The authors report that the observed dose-response curve suggests the daily intake needed to prevent collagen-related pathologies is in the range of 75 to 110 mg/d rather than the WHO recommendation of 45 mg/d.
Hujoel PP, Hujoel MLA Am J Clin Nutr, 2022. PMID 34396385
2022 / Phase 2 randomized, double-blind, placebo-controlled trial
In a phase 2 trial, 42 patients with treated open-angle glaucoma were randomized 2:1 to ascending doses of oral nicotinamide (1000-3000 mg) and pyruvate (1500-3000 mg) or placebo, with 32 completing the study. Over a median follow-up of 2.2 months, the number of improving visual field test locations was significantly higher in the intervention group than placebo (median [IQR], 15 [6-25] vs 7 [6-11]; P = .005). Rates of change in pattern standard deviation suggested improvement (median, -0.06 vs 0.02 dB/week; P = .02), whereas mean deviation (P = .35) and visual field index (P = .71) did not differ significantly. No serious adverse events were reported.
De Moraes CG, John SWM, Williams PA, et al. JAMA Ophthalmol, 2022. PMID 34792559
2022 / Community-based randomized controlled trial
A randomized controlled trial examined the effects of cold-water immersion (20-30°C for 20 minutes/day over 4 weeks) versus a control group in 76 acute gout patients in Indonesia. Compared to pre-intervention and control, cold-water immersion led to significant pain alleviation, improved joint mobility, physical activity, stress, anxiety, and quality of life at weeks 2 and 4, while depression decreased by week 4. Path analysis showed cold-water immersion directly mediated pain alleviation (β = -0.46, p ≤ .001) and promoted quality of life (β = 0.16, p = .01).
Kurniasari MD, Monsen KA, Weng SF, et al. Biol Res Nurs, 2022. PMID 35021915
2022 / Randomized, placebo-controlled clinical trial
A randomized, placebo-controlled trial evaluated the effects of 100 mg of açaí extract for three months versus placebo in 30 individuals with chronic tinnitus. The açaí group experienced a reduction in tinnitus discomfort assessed via the Tinnitus Handicap Inventory (p = 0.006). Significant differences in common anxiety disorder symptoms were observed in the placebo group (p = 0.016), but no significant differences were observed for oxidative metabolism biomarkers, although values decreased post-treatment in all groups.
Oppitz SJ, Garcia MV, Bruno RS, et al. Codas, 2022. PMID 35107519
2022 / Double-blind randomized phase I clinical trial
A double-blind phase I trial evaluated oral nicotinamide riboside (NR; 1,000 mg daily) versus placebo for 30 days in 30 newly diagnosed, treatment-naive Parkinson's disease patients. NR was well tolerated and caused a significant, though variable, increase in cerebral NAD levels and related CSF metabolites. Patients with increased brain NAD levels showed altered cerebral metabolism that was linked to mild clinical improvement. NR also upregulated processes linked to mitochondrial, lysosomal, and proteasomal function in blood and/or muscle, and lowered inflammatory cytokines in serum and CSF.
Brakedal B, Dölle C, Riemer F, et al. Cell Metab, 2022. PMID 35235774
2022 / Randomized controlled trial
In a randomized controlled trial, 182 community adults were assigned to perform three kind acts for others, three kind acts for themselves, or list daily activities (control) one day per week for 4 weeks. CTRA gene expression was assessed via RNA sequencing of dried blood spots at baseline and 5 weeks later. Participants randomized to perform kind acts for others demonstrated significant reductions in CTRA gene expression relative to controls. Participants randomized to kind acts for themselves showed significant reductions only among those who failed to adhere to the self-kindness protocol, while fully adherent participants showed no change and did not differ from controls.
Regan A, Fritz MM, Walsh LC, et al. Brain Behav Immun, 2022. PMID 35905861
2021 / Phase 1 double-blind randomized placebo-controlled trial
Twenty men with alcohol use disorder-related cirrhosis were randomized 1:1 to receive a single placebo or fecal microbiota transplant (FMT) enema from a donor enriched in Lachnospiraceae and Ruminococcaceae. At day 15, craving was reduced in 90% of the FMT group versus 30% in placebo (P = 0.02), accompanied by lower urinary ethylglucuronide/creatinine (P = 0.03), improved cognition and psychosocial quality of life, reduced IL-6, and increased microbial diversity and butyrate/isobutyrate. Over 6 months, patients with serious adverse events (SAEs) were significantly higher in placebo compared to FMT (8 vs. 2, P = 0.02), as were AUD-related SAEs (7 vs. 1, P = 0.02).
Bajaj JS, Gavis EA, Fagan A, et al. Hepatology, 2021. PMID 32750174
2021 / Parallel, double-blind, randomized, placebo-controlled trial
In a randomized, double-blind trial, 80 women received either 500 mg of celery seed or placebo 3 times a day for 6 weeks. At week 6, improvement in the total FSFI score was significantly greater with celery seed than placebo (P < 0.001). This increase was mainly driven by improvements in sexual desire (p < 0.001), arousal (p < 0.001), lubrication (p < 0.001), and pain (p = 0.033) domains. No serious side effects were observed in either group.
Hessami K, Rahnavard T, Hosseinkhani A, et al. J Ethnopharmacol, 2021. PMID 32971161
2021 / Randomized controlled trial
A randomized controlled trial assigned 48 obese women with PCOS to receive a low-calorie diet with either 5 g/day thylakoid-rich spinach extract or 5 g/day placebo for 12 weeks. Compared to placebo, the spinach extract group had a greater increase in serum omentin-1 (10.90 vs. 3.87 ng/L; p < .001) and greater reductions in fat mass (-5.19 vs. -1.35 kg; p < .001), neopterin (-0.66 vs. -0.38 nmol/L; p = .003), and chemerin (-41.24 vs. -11.26 ng/L; p < .001). Significant decreases in other anthropometric indices and insulin resistance were also observed in the thylakoid group compared to placebo (p < .001 for all parameters).
Pourteymour Fard Tabrizi F, Abbasalizad Farhangi M, Vaezi M, et al. Phytother Res, 2021. PMID 33368745
2021 / Prospective single-arm pilot study
Ten cirrhotic patients experiencing muscle cramps at least once per week were administered an oral taurine solution (1 g thrice daily) for 4 weeks, followed by a 4-week discontinuation. Muscle cramp scores decreased in seven patients by weeks 4 and 8. Median cramp scores dropped from 21 (IQR: 8-84) at baseline to 6.5 (IQR: 3-12, p=0.126) at week 4 and 5 (IQR: 1.5-56, p=0.066) at week 8. Improvements in muscle cramps at week 4 were reported by 60% of patients with low baseline taurine levels and 80% of patients with normal or higher baseline levels.
Jang ES, Hwang SH, Kim JW, et al. Yonsei Med J, 2021. PMID 33381931
2021 / Randomized controlled trial
A randomized trial investigated whether daily oral almond consumption increases UVB resistance and reduces skin aging in 39 healthy Asian women (18-45 years, Fitzpatrick skin type II-IV). Participants consumed either 1.5 oz of almonds or 1.8 oz of pretzels daily for 12 weeks. The minimal erythema dose (MED) increased in the almond group compared to the pretzel group. No differences were observed between groups in facial Allergan roughness, melanin, hydration, or sebum.
Li JN, Henning SM, Thames G, et al. J Cosmet Dermatol, 2021. PMID 33491323
2021 / Randomized comparative trial
Sixty patients with female pattern hair loss were randomized to receive either pumpkin seed oil (n = 30) or minoxidil 5% foam (n = 30) for 3 months. In the pumpkin seed oil group, hair shaft diversity significantly decreased from 30.5 ± 6.2% to 24.0 ± 4.02 (P < .001) and vellus hairs decreased from 22.5 ± 4.9 to 15.8 ± 2.2 (P < .001), while upright regrowing hairs increased from 0.13 ± 0.5 to 0.9 ± 1.0 (P < .001). In the minoxidil group, hair shaft diversity decreased from 31.5 ± 6.3% to 21.3 ± 2.2 (P < .001) and vellus hairs decreased from 24.7 ± 6.4 to 19.5 ± 5.4 (P = .02).
NANO counterpoint →
Ibrahim IM, Hasan MS, Elsabaa KI, et al. J Cosmet Dermatol, 2021. PMID 33544448